These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11330360)

  • 41. Multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Orsi GB; Franchi C; Giordano A; Rocco M; Ferraro F; Mancini C; Venditti M
    J Chemother; 2008 Apr; 20(2):219-24. PubMed ID: 18467249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
    Vitkauskiene A; Dambrauskiene A; Cerniauskiene K; Rimdeika R; Sakalauskas R
    Scand J Infect Dis; 2013 Mar; 45(3):213-8. PubMed ID: 23113773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular epidemiology of nosocomial infection associated with multi-resistant Acinetobacter baumannii by infrequent-restriction-site PCR.
    Wu TL; Su LH; Leu HS; Chiu CH; Chiu YP; Chia JH; Kuo AJ; Sun CF
    J Hosp Infect; 2002 May; 51(1):27-32. PubMed ID: 12009817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Outbreak of multiresistant Acinetobacter baumannii infection].
    Onarheim H; Høivik T; Harthug S; Digranes A; Mylvaganam H; Vindenes HA
    Tidsskr Nor Laegeforen; 2000 Mar; 120(9):1028-33. PubMed ID: 10833961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
    Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
    Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
    Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa.
    Marais E; de Jong G; Ferraz V; Maloba B; Dusé AG
    Am J Infect Control; 2004 Aug; 32(5):278-81. PubMed ID: 15292892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.
    Seward RJ; Lambert T; Towner KJ
    J Med Microbiol; 1998 May; 47(5):455-62. PubMed ID: 9879947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acinetobacter, a nosocomial pathogen. Contribution of experimental models].
    Joly-Guillou ML; Hidri N; Wolff M
    Presse Med; 2002 Apr; 31(14):651-6. PubMed ID: 11995384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Origin of transferable cefotaxime resistance in a clinical isolate of Escherichia coli by mutation.
    Králiková K; Krcméry V; Hupková M; Blahova J
    J Chemother; 1994 Feb; 6(1):15-9. PubMed ID: 8071671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiresistant acinetobacter in the UK: how big a threat?
    Coelho J; Woodford N; Turton J; Livermore DM
    J Hosp Infect; 2004 Nov; 58(3):167-9. PubMed ID: 15501329
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biological characteristics and antibiotic sensitivity of Acinetobacter strains].
    Maruashvili IA; Shubitidze AE; Gabisoniia TG; Pkhakadze TIa; Rekhviashvili NV
    Antibiot Khimioter; 1995 Aug; 40(8):28-31. PubMed ID: 8713434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inter-species population dynamics enhance microbial horizontal gene transfer and spread of antibiotic resistance.
    Cooper RM; Tsimring L; Hasty J
    Elife; 2017 Nov; 6():. PubMed ID: 29091031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmid mediated silver resistance in Acinetobacter baumannii.
    Deshpande LM; Chopade BA
    Biometals; 1994 Jan; 7(1):49-56. PubMed ID: 8118173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic resistant Escherichia coli in a Sudanese hospital.
    Musa HA; Shears P
    J Hosp Infect; 1998 Feb; 38(2):148-50. PubMed ID: 9522294
    [No Abstract]   [Full Text] [Related]  

  • 58. Learning from losers.
    Kirkup B
    Elife; 2017 Nov; 6():. PubMed ID: 29148975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling antibiotic resistance in the microbiota using multi-level Petri Nets.
    Bardini R; Di Carlo S; Politano G; Benso A
    BMC Syst Biol; 2018 Nov; 12(Suppl 6):108. PubMed ID: 30463550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meeting Report: The XXVth Slovak-Czech Conference on Hemostasis and Thrombosis (with International Participation), Martin, Slovak Republic.
    Stanciakova L; Kubisz P; Stasko J; Maly J
    Semin Thromb Hemost; 2019 Feb; 45(1):117-120. PubMed ID: 30566965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.